Supplemental Figure 1 from Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade

Authors :: James W. Young
Brian C. Betts
Katharine C. Hsu
Glenn Heller
David J. Chung
Sneh Sharma
Lillian R. Talbot
Erin T. St. Angelo
Justin A. Shyer
Shane A. Curran
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: TG101348 and ruxolitinib inhibit JAK2 mediated STAT5 and STAT3 phosphorylation.

Full Text Access

Tools